Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

We use the best available evidence to develop recommendations that guide decisions in health, public health and social care.

you can comment on draft recommendations the final recommendations are published published guidance is being reviewed. We'll use the information you provide on this form to contact you about the ...

For further information on how we select topics for development, please see our page about topic selection ...

For further information on the guideline development process, please see how we develop NICE guidelines ...

A list of downloadable documents created during development.

Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...

It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...

To find BTS, NICE or SIGN guidance on related topics, including guidance in development, see the BTS guidelines, the NICE topic page on asthma and the SIGN guidelines. For full details of the evidence ...

This summary report is based on the NICE assumptions used in the resource impact template. Users can amend the 'Inputs and eligible population' and 'Unit costs' worksheets in the template to reflect ...

These sections briefly explain why the committee made the recommendations and how they might affect practice. As this guideline applies to England and Scotland, the perspective was for both England ...